2025-11-14T18:29:55-07:00 2024-12-31 262176601 EASY OFFICE DBA JITASA 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 990 2024-01-01 814011501 PATIENTS FOR AFFORDABLE DRUGS PATI 2027347555 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 CHARLES HURLEY TREASURER 2027347555 2025-11-14 1 1 JEREMY CORK P01544850 2082874777 2025-11-14 2024 2025-03-06 01:10:19Z DAVID MITCHELL 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 2630590 0 X www.patientsforaffordabledrugs.org X 2016 MD PATIENTS FOR AFFORDABLE DRUGS IS THE ONLY NATIONAL PATIENT ADVOCACY ORGANIZATION FOCUSED EXCLUSIVELY ON LOWERING PRESCRIPTION DRUG PRICES. WE EMPOWER AND MOBILIZE PATIENTS AND ALLIES, HOLD ACCOUNTABLE THOSE IN POWER, AND FIGHT TO SHAPE AND ACHIEVE SYSTEM-CHANGING POLICIES THAT MAKE PRESCRIPTION DRUGS AFFORDABLE FOR ALL PEOPLE IN THE UNITED STATES. 4 4 9 4 0 0 1461976 1643681 40000 0 40 29 816001 986880 2318017 2630590 0 0 0 0 1160090 1083116 0 0 0 458609 924326 1618699 2007442 699318 623148 1271094 2131080 107763 319573 1163331 1811507 THE PURPOSE OF PATIENTS FOR AFFORDABLE DRUGS IS TO PROMOTE HEALTH BY RAISING THE VOICES OF PATIENTS AND THEIR FAMILIES ON THE CAUSES OF HIGH DRUG PRICES AND TO HELP EDUCATE THEM ABOUT HOW THEY CAN BE A PART OF THE DISCUSSION AND WORK TO MAKE REFORMS TO THE US SYSTEM OF DRUG PRICING IN THE PRIVATE AND PUBLIC SECTORS. 0 0 1654852 0 0 GENERAL PROGRAM: THE GENERAL PROGRAM CONSISTS OF BUILDING A PATIENT-CENTERED COMMUNITY THAT IS FINANCIALLY INDEPENDENT FROM ANY GROUP THAT PROFITS FROM THE DEVELOPMENT OR DISTRIBUTION OF PRESCRIPTION DRUGS. WE EDUCATE THE PUBLIC, PATIENTS, AND KEY STAKEHOLDERS ABOUT THE CHALLENGES THAT PEOPLE FACE UNDER THE CURRENT DRUG DEVELOPMENT AND PRICING FRAMEWORK. 75842 0 0 WEST HEALTH 2023 PILOT RECRUITMENT PROJECT: GRASSROOTS RECRUITMENT AND OUTREACH STRATEGY WITH AN EMPHASIS ON IDENTIFYING AND ENGAGING PATIENTS FROM COMMUNITIES WHO ARE DISPROPORTIONATELY HARMED BY HIGH DRUG PRICES. 60000 0 0 THE HOPEWELL FUND - IMPACT PROJECT: A GENERAL SUPPORT GRANT WITH A FOCUS ON RECRUITMENT AND TRAINING OF PATIENTS IN COLORADO, MICHIGAN AND VIRGINIA WHO TAKE HIGH COST PRESCRIPTION MEDICATION. 0 0 0 1790694 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 8 0 1 9 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 4 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 1 1 0 X X EASY OFFICE DBA JITASA 2082874777 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 MERITH BASEY EXECUTIVE DIRECTOR 28 12 X 237297 0 8794 WENDY CHEW CHIEF OPERATING OFFICER 28 12 X 196359 0 22789 TEMI AMOYE COMMUNITY ORGANIZING AND ADVOCACY DIRECTOR 28 12 X 129667 0 5262 EMMA SANDS DIRECTOR OF MEDIA AND COMMUNICATIONS 28 12 X 119376 0 5140 ALYSON BANCROFT DIRECTOR OF LEGISLATION, POLICY AND ALLIANCES 28 12 X 42388 0 1846 DAVID MITCHELL PRESIDENT/FOUNDER 28 12 X X 0 0 0 CAL LAROCHE TREASURER 0.25 X X 0 0 0 CHARLES HURLEY BOARD MEMBER 0.25 X 0 0 0 TOMI FADEYI-JONES BOARD MEMBER 0.25 X 0 0 0 725087 0 43831 4 0 1 0 TRILOGY INTERACTIVE LLC PO BOX 4177 MOUNTAIN VIEW CA 940404177 STRATEGIC CONSULTING 124625 FAIRMARK PARTNERS LLP 1825 7TH STREET NW SUITE 821 WASHINGTON DC 20001 LEGAL SERVICES 110000 FIREHOUSE STRATEGIES LLC 1501 M STREET NW SUITE 1100 WASHINGTON DC 20005 STRATEGIC CONSULTING 110000 3 0 0 0 0 0 1643681 0 1643681 0 29 0 0 29 0 0 0 0 0 0 0 0 0 0 0 0 0 REVENUE FROM REIMBURSEMENT (RELATED ORGANIZATION) 900099 986863 986863 0 0 17 17 0 0 986880 2630590 986880 0 29 516291 482862 33429 450875 450875 26664 23111 3553 20149 2028 18121 69137 67958 1179 111201 111201 190529 185284 5245 339322 338931 391 20941 17564 3377 9274 9274 145449 4215 141234 67908 66244 1664 1918 1918 2433 2198 235 7550 924 6626 TELEPHONE & TELECOMMUNICATIONS 9129 9129 0 0 TRAINING 8468 6817 1651 0 RECRUITING 7307 7307 0 0 OTHER 2897 2854 43 0 2007442 1790694 216748 0 660210 1025867 28756 28785 455000 637500 6359 6993 20279 13921 3075 6358 117694 425577 1271094 2131080 107763 40900 278673 107763 319573 X 718331 1811507 445000 0 1163331 1811507 1271094 2131080 623148 0 0 0 25028 0 X 0 1 X 1 0 X 874759 578328 1453409 1461976 1643681 6012153 874759 578328 1453409 1461976 1643681 6012153 4223461 1788692 1629 95 54 40 29 1847 574850 816001 986880 2377731 8391731 65000 0.21315 0.18264 X "PATIENTS FOR AFFORDABLE DRUGS (P4AD) MEETS THE FACTS AND CIRCUMSTANCES TEST IN 26 CFR § 1.170A-9(F)(3) AS A PUBLICLY SUPPORTED ORGANIZATION. THE ORGANIZATION HAS CREATED A ROBUST COMMUNITY OF PATIENTS OVER ITS FIRST FIVE YEARS IN OPERATION AND IS DEMONSTRABLY A PUBLIC CHARITY THAT IS SERVING PEOPLE IN NEED, AND ESPECIALLY LOWER INCOME AMERICANS WHO CANNOT AFFORD THEIR PRESCRIPTION DRUGS. P4AD IS THE ONLY FULLY INDEPENDENT NATIONAL PATIENT ORGANIZATION FOCUSED EXCLUSIVELY ON PROMOTING POLICIES THAT WILL LOWER THE PRICES OF PRESCRIPTION DRUGS. WE DO NOT ACCEPT FUNDING FROM ANY ORGANIZATIONS THAT PROFIT FROM THE DEVELOPMENT OR DISTRIBUTION OF PRESCRIPTION DRUGS. IN THE FIRST FIVE YEARS OF OUR EXISTENCE, P4AD STRATEGICALLY CHOSE TO AVOID ASKING PATIENTS FOR FINANCIAL CONTRIBUTIONS BECAUSE WE KNEW MANY WERE ALREADY STRUGGLING TO PAY HIGH PRICES FOR THEIR MEDICINES - THAT'S WHY THEY ENGAGED WITH US. ONE OUT OF FOUR AMERICANS REPORT IT IS VERY DIFFICULT FOR THEM TO AFFORD THEIR PRESCRIPTION DRUGS[1]. ALMOST ONE IN THREE SAY THEY HAVE NOT TAKEN PRESCRIPTION MEDICATIONS AS DIRECTED BECAUSE OF COSTS. PATIENTS NEEDED A PLATFORM TO AMPLIFY THEIR STORIES TO POLICYMAKERS AND ELECTED OFFICIALS, AND WE BELIEVED IT WAS INAPPROPRIATE TO ASK THE VERY PEOPLE WHO ARE UNABLE TO AFFORD THE LIFESAVING MEDICATIONS THEY NEED TO SEND US MONEY-ESPECIALLY AS WE WERE NEW ON THE SCENE, AND HAD NOT ESTABLISHED A RECORD OF EFFECTIVENESS. SEE 26 CFR § 1.170A-9(F)(3)(III)(B) ("IN DETERMINING WHAT IS A "REPRESENTATIVE NUMBER OF PERSONS," CONSIDERATION WILL BE GIVEN TO THE TYPE OF ORGANIZATION INVOLVED, THE LENGTH OF TIME IT HAS BEEN IN EXISTENCE, AND WHETHER IT LIMITS ITS ACTIVITIES TO A PARTICULAR COMMUNITY OR REGION OR TO A SPECIAL FIELD WHICH CAN BE EXPECTED TO APPEAL TO A LIMITED NUMBER OF PERSONS"). INSTEAD OF SEEKING FUNDING FROM THOSE WHO FACE DISPROPORTIONATE FINANCIAL HARM FROM HIGH DRUG PRICES, WE SOUGHT FUNDING FROM OTHER SOURCES AND ASKED PATIENTS FOR THEIR PERSONAL STORIES AND EMAIL ADDRESSES WHICH FORM THE BASIS OF - THE CURRENCY OF - ALL OUR ORGANIZING AND COMMUNICATIONS WORK. SEE 26 CFR § 1.170A-9(F)(3)(II) ("CONSIDERATION WILL ALSO BE GIVEN TO THE FACT THAT AN ORGANIZATION, IN ITS EARLY YEARS OF EXISTENCE, MAY LIMIT THE SCOPE OF ITS SOLICITATION TO PERSONS DEEMED MOST LIKELY TO PROVIDE SEED MONEY IN AN AMOUNT SUFFICIENT TO ENABLE IT TO COMMENCE ITS CHARITABLE ACTIVITIES AND EXPAND ITS SOLICITATION PROGRAM"). THE CORE OF OUR WORK IS TO RAISE UP PATIENT STORIES, AMPLIFY THEIR VOICES AND ENGAGE AND TRAIN PEOPLE TO COMMUNICATE ON THEIR OWN BEHALF. SINCE FEBRUARY, 2017 WHEN WE PUBLICLY LAUNCHED P4AD, WE HAVE COLLECTED MORE THAN 38,000 PATIENT STORIES WHICH ARE DISPLAYED ON OUR WEBSITE. PATIENTS FOR AFFORDABLE DRUGS, MAP OF STORIES COLLECTED, AT HTTPS://MAP.PATIENTSFORAFFORDABLEDRUGS.ORG/ (LAST ACCESSED OCTOBER 23, 2025). OUR EMAIL COMMUNITY HAS GROWN FROM ZERO TO MORE THAN 420,000 NOW, DEMONSTRATING BROAD SUPPORT AND ENGAGEMENT WITH THE PEOPLE WE ARE WORKING TO SERVE. OUR ACTIVIST SMS TEXT PROGRAM ENGAGES MORE THAN 88,000 AMERICANS - A SIGNIFICANT PROPORTION OF WHOM READ AND TAKE ACTION WEEKLY PROMPTED BY OUR COMMUNICATIONS. WE NOW HAVE OVER 300 TRAINED ADVOCATES ALL ACROSS THE COUNTRY WHO GIVE OF THEIR TIME AND ENERGY IN SUPPORT OF P4AD. OUR PATIENT ADVOCATES WRITE BLOGS, LETTERS TO THE EDITOR, SPEAK TO THE NEWS MEDIA, AND VISIT WITH THEIR ELECTED OFFICIALS. THEY MAKE THEIR STORIES KNOWN AND RAISE THEIR VOICES FOR CHANGE. AS WE HAVE BUILT A RECORD OF EFFECTIVENESS-IN PARTICULAR BY HAVING TEN OF OUR ADVOCATES MEET WITH THE PRESIDENT, 16 TESTIFY IN CONGRESS, MORE THAN 80 APPEAR IN MAJOR NEWS STORIES-WE HAVE IMPLEMENTED A FUNDRAISING AND DEVELOPMENT STRATEGY TO BROADEN OUR BASE OF FINANCIAL SUPPORT. NOW THAT WE ARE ESTABLISHED AND CAN POINT TO CONCRETE ACHIEVEMENTS ON BEHALF OF PATIENTS, WE HAVE BEGUN TO ASK PATIENTS AND POTENTIAL ALLIES FOR SMALL DONATIONS, AND WE ARE INCREASING THE FUNDING FROM THOSE SOURCES, IN ADDITION TO ACQUIRING THEIR STORIES, EMAILS AND ENGAGEMENT OF THEIR TIME AND EFFORT IN SUPPORT OF OUR WORK. WE ARE ALSO SEEKING TO INCREASE GRANTS FROM PUBLIC CHARITIES AS WELL, AND HAVE IMPROVED THE PUBLIC SUPPORT PERCENTAGE. 26 CFR § 1.170A-9(F)(3)(II). REGARDLESS, IF INDIVIDUALS ARE WILLING TO DONATE THEIR TIME, VOICE AND STORIES IN LARGE ENOUGH NUMBERS IN SUPPORT OF A CAUSE IN WHICH THEY BELIEVE, THOSE EXPRESSIONS AND ACTIONS ESTABLISH PUBLIC SUPPORT. P4AD CLEARLY PROVIDES THESE SERVICES TO THE BENEFIT OF THE GENERAL PUBLIC ON A CONTINUOUS BASIS AND SUPPORTS GENERAL REFORMS THAT HAVE THE BACKING OF 80 PERCENT OF AMERICANS[2]. IT IS TO THE BENEFIT OF THE GENERAL PUBLIC THAT THE COSTS OF PRESCRIPTION DRUGS BE LOWER, AND P4AD CENTERS ITS PROGRAM AROUND SERVING AND COLLECTING STORIES FROM THE GENERAL PUBLIC THAT IT SERVES. 26 CFR § 1.170A-9(F)(3)(III)(D). FOR THESE REASONS, AND THE FACT WE HAVE BEEN PROACTIVELY FUNDRAISING SINCE 2022, WE BELIEVE THAT THE FACTS AND CIRCUMSTANCES CLEARLY INDICATE THAT P4AD IS A PUBLICLY SUPPORTED ORGANIZATION. [1] KFF, "PUBLIC OPINION ON PRESCRIPTION DRUGS AND THEIR PRICES" (APRIL 5, 2022), AT HTTPS://WWW.KFF.ORG/HEALTH-COSTS/POLL-FINDING/PUBLIC-OPINION-ON-PRESCRIPTION-DRUGS-AND-THEIR-PRICES/ (LAST ACCESSED OCTOBER 20, 2022). [2] KFF HEALTH TRACKING POLL - MAY 2021: PRESCRIPTION DRUG PRICES TOP PUBLIC'S HEALTH CARE PRIORITIES HTTPS://WWW.KFF.ORG/HEALTH-COSTS/POLL-FINDING/KFF-HEALTH-TRACKING-POLL-MAY-2021/ (LAST ACCESSED OCTOBER 20, 2022)" Schedule A, Part II, Line 10 REVENUE FROM REIMBURSEMENT (RELATED ORGANIZATION). RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 0 0 0 0 20279 13921 6358 0 0 0 0 6358 LEASE ROU ASSET 266502 DUE FROM C4 159075 425577 LEASE LIABILITIES - ROU 278673 278673 X 2630590 0 0 0 0 0 2630590 0 0 0 2630590 2007442 0 0 0 0 0 2007442 0 0 0 2007442 Schedule D, Part X, Line 2 THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THAT GUIDANCE, THE ORGANIZATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50 PERCENT LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THERE WERE NO UNRECOGNIZED TAX BENEFITS IDENTIFIED OR RECORDED AS LIABILITIES FOR FISCAL YEAR 2024. THE ORGANIZATION FILES FORM 990 IN THE U.S. FEDERAL JURISDICTION. THE ORGANIZATION IS GENERALLY NO LONGER SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE FOR YEARS BEFORE 2020. 0 0 0 0 0 0 0 0 0 MERITH BASEY EXECUTIVE DIRECTOR 237297 0 0 0 0 0 0 0 8794 0 246091 0 0 0 WENDY CHEW CHIEF OPERATING OFFICER 196359 0 0 0 0 0 0 0 22789 0 219148 0 0 0 Form 990, Part VI, Section B, Line 11b THE FORM 990 DRAFT IS SHARED WITH THE BOARD MEMBERS VIA EMAIL. Form 990, Part VI, Section B, Line 15 THE EXECUTIVE DIRECTOR'S COMPENSATION WAS REVIEWED AND APPROVED BY THE FOUNDER, DAVID MITCHELL. ALL STAFF THAT REPORTS TO THE EXECUTIVE DIRECTOR HAS THEIR COMPENSATION REVIEWED AND APPROVED BY THE EXECUTIVE DIRECTOR WHO CONSULTED WITH THE FOUNDER FOR COMPENSATION DECISIONS. Form 990, Part VI, Section C, Line 19 THE FORM 990 IS MADE AVAILABLE TO THE PUBLIC VIA GUIDESTAR.ORG AND IRS.GOV WEBSITES. GOVERNING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REASONABLE REQUEST. PATIENTS FOR AFFORDABLE DRUGS NOW 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 823044855 MOBILIZE PATIENTS TO SUPPORT LEGISLATION TO LOWER DRUG PRICES. DC 501(c)(4) N/A N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 PATIENTS FOR AFFORDABLE DRUGS NOW o 849123 ACTUAL COST PATIENTS FOR AFFORDABLE DRUGS NOW n 137740 ACTUAL COST